New advances in models and strategies for developing anti-obesity drugs.
about
MicroRNA Functions in Brite/Brown Fat - Novel Perspectives towards Anti-Obesity StrategiesMetabolic Disorder in Chronic Obstructive Pulmonary Disease (COPD) Patients: Towards a Personalized Approach Using Marine Drug Derivatives.Antiobesity pharmacotherapy: new drugs and emerging targetsBidens pilosa and its active compound inhibit adipogenesis and lipid accumulation via down-modulation of the C/EBP and PPARγ pathwaysNovel therapeutics for type 2 diabetes: insulin resistance.Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.Correlation Between Nasal Epithelial Injury and In Vitro Cytotoxicity Using a Series of Small Molecule Protein Tyrosine Phosphatase 1B Inhibitors Investigated for Reversal of Leptin Resistance in Obesity.
P2860
Q26830503-3D4A18F5-3451-4102-84E9-3C8C8454194AQ30235126-7F041C45-FCB1-4246-8919-8EAF80C72F43Q30354242-C36B2978-9163-4B1D-8E7E-C41102E7FD29Q36785378-157E52B6-C7D1-4C99-AB14-0A9051C82427Q38259507-FF7AD57E-3FB4-4EBC-AAB6-535960E59953Q38758765-F88F6EE2-233B-4395-80AE-AD720215A253Q50954720-3F30CE15-E507-469B-9992-446B5A497071
P2860
New advances in models and strategies for developing anti-obesity drugs.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
New advances in models and strategies for developing anti-obesity drugs.
@ast
New advances in models and strategies for developing anti-obesity drugs.
@en
type
label
New advances in models and strategies for developing anti-obesity drugs.
@ast
New advances in models and strategies for developing anti-obesity drugs.
@en
prefLabel
New advances in models and strategies for developing anti-obesity drugs.
@ast
New advances in models and strategies for developing anti-obesity drugs.
@en
P2093
P2860
P1476
New advances in models and strategies for developing anti-obesity drugs.
@en
P2093
Erik S Blomain
Gilbert W Kim
Jieru E Lin
P2860
P304
P356
10.1517/17460441.2013.792804
P407
P577
2013-04-29T00:00:00Z